Accession | ARO:3000452 |
Definition | Fluoroquinolones inhibit type II and type IV topoisomerases (2 strand breaking enzymes) such as GyrA/GyrB and ParC/ParE. Point mutations in the associated gyrA and parC genes, in particular in the 'quinolone resistance determining region' (QRDR), give rise to resistance to the class. |
Resistance Mechanism | antibiotic target alteration |
Classification | 5 ontology terms | Show |
Parent Term(s) | 1 ontology terms | Show |
Sub-Term(s) | 4 ontology terms | Show + fluoroquinolone resistant parC [AMR Gene Family] + fluoroquinolone resistant gyrB [AMR Gene Family] + fluoroquinolone resistant gyrA [AMR Gene Family] + fluoroquinolone resistant parE [AMR Gene Family] |
Publications | Hooper DC. 1999. Drug Resist Updat 2(1): 38-55. Mechanisms of fluoroquinolone resistance. (PMID 11504468) Wohlkonig A, et al. 2010. Nat Struct Mol Biol 17(9): 1152-1153. Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. (PMID 20802486) Maruri F, et al. 2012. J Antimicrob Chemother 67(4): 819-831. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. (PMID 22279180) |